Clinical Trials Browser

Recruiting × Adenocarcinoma of Lung × tislelizumab × Clear all

NCT06056115 2023-09-28

Efficacy and Safety of Tislelizumab for Lung Adenocarcinoma With Asymptomatic Brain Metastatic

Phase NA Recruiting

Adenocarcinoma of Lung